People
-
ANZ pharmas strengthen leadership teams
- Fri Aug 21
Biogen, MSD and Lundbeck have taken on senior people this month as top executives move around and companies have their choice of talent.
Read more -
Global CEO slams Aussie pharma for failing to think differently
- Mon Aug 17
Lexicon Pharma CEO Professor Mike Exton says the ANZ industry has been stuck on the same PBS mantra for 20 years and it’s time they moved on.
Read more -
Pharma expert proposes radical access rethink
- Fri Aug 14
Incentives for biotechs to commercialise innovations in Australia along with a private funding model to bridge the gap between TGA registration and the PBS.
Read more -
AbbVie executives join MA, Pharmac
- Fri Aug 14
Jodie Wilson appointed to key policy role in MA’s senior team as NZ head moves to Pharmac in significant gains for the industry associations.
Read more -
Who’s moved into an advisory role?
- Fri Aug 14
Leading corporate affairs specialists – one from pharma and the other a leading patient group – have joined advisory firms. See who has gone, and where.
Read more -
Thanks so much for making me unemployed
- Wed Aug 12
OP-ED: Ex-pharma employees are taking to social media in droves to announce how thrilled they are to be made redundant, but are those left behind any better off?
Read more -
DBG Health names Greg Hunt as Board director
- Wed Aug 12
The company put out a statement announcing the former Health Minister’s directorship, but it seems Greg Hunt has been a DBG director for some time.
Read more -
Adam Wyldeck starts new role in the US
- Mon Aug 10
One of Australia’s most successful corporate affairs exports, Adam Wyldeck left J&J last month for an exciting senior role with AstraZeneca. He tells MedNews why he wants to stay in the US.
Read more